Skip to main content
OpenTrials

Clinical trial condition

Male Urogenital Diseases

Explore clinical trials studying Male Urogenital Diseases. Study availability and eligibility vary by location and protocol.

20,861 public trials 3,480 recruiting studies
Refine in advanced search Browse all conditions

Male Urogenital Diseases trial results

Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

NCT07309445

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 17 locations
View Trial Details
Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

NCT07319871

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
  • The Christie NHS Foundation Trust Christie Hospital Manchester, United Kingdom
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Recruiting

A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection

NCT07202949

Conditions
Chronic Urinary Tract Infection, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +5 more
Locations
  • University College London Hospital (UCLH), UCLH NHS Foundation Trust London, United Kingdom
  • Whittington Hospital, Whittington Health NHS Trust London, United Kingdom
  • St Mary's Hospital, Manchester University NHS Foundation Trust Manchester, United Kingdom
  • Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

NCT06637423

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0053) Bakersfield, California, United States
  • Moffitt Cancer Center ( Site 0057) Tampa, Florida, United States
  • Northwestern University ( Site 0051) Chicago, Illinois, United States
  • Johns Hopkins University ( Site 0055) Baltimore, Maryland, United States
View all 13 locations
View Trial Details

Related conditions